Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVECOVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022

  • Angela Mc Rose*
  • , Nathalie Nicolay
  • , Virginia Sandonis Martín
  • , Clara Mazagatos
  • , Goranka Petrović
  • , Joaquin Baruch
  • , Sarah Denayer
  • , Lucie Seyler
  • , Lisa Domegan
  • , Odile Launay
  • , Ausenda Machado
  • , Cristina Burgui
  • , Roberta Vaikutyte
  • , F. Annabel Niessen
  • , Isabela I. Loghin
  • , Petr Husa
  • , Nassera Aouali
  • , George Panagiotakopoulos
  • , Kristin Tolksdorf
  • , Judit Krisztina Horváth
    • Jennifer Howard, Francisco Pozo, Virtudes Gallardo, Diana Nonković, Aušra Džiugytė, Nathalie Bossuyt, Thomas Demuyser, Róisín Duffy, Liem Binh Luong Nguyen, Irina Kislaya, Iván Martínez-Baz, Giedre Gefenaite, Mirjam J. Knol, Corneliu Popescu, Lenka Součková, Marc Simon, Stella Michelaki, Janine Reiche, Annamária Ferenczi, Concepción Delgado-Sanz, Zvjezdana Lovrić Makarić, John Paul Cauchi, Cyril Barbezange, Els Van Nedervelde, Joan O'Donnell, Christine Durier, Raquel Guiomar, Jesús Castilla, Indrė Jonikaite, Patricia Cjl Bruijning-Verhagen, I-MOVE-COVID-19 hospital study team, VEBIS hospital study team, Members of the I-MOVE-COVID-19 and VEBIS hospital study teams (in addition to authors above)
*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVECOVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Biochemistry, Genetics and Molecular Biology

Agricultural and Biological Sciences